Fecal Transfer from Moms to Babies After C-Section: Trial Results

Tiny doses of maternal poo mixed with breast milk and given to Cesarean-born infants makes their gut microbiota resemble those of babies born vaginally.

ruth williams
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, MVALIGURSKY

The composition of gut microbes in babies born via Cesarean section tends to differ from those in babies born vaginally, prompting speculation that this may have long-term health consequences. To enrich for beneficial bugs in babies’ bellies after C-section, researchers have performed mom-to-infant microbial transplants, described today (October 1) in Cell. In a clinical trial in which seven Cesarean-delivered babies were fed tiny amounts of their mothers’ fecal material, it was found that the babies’ guts became colonized with the sorts of bacteria normally present in infants delivered vaginally. While the procedure produced no ill effects in the infants, there are no data on whether it has any benefits to the baby, and experts warn it may be dangerous for mothers to attempt such a treatment themselves.

“This is a very well-balanced, important, and clinically relevant contribution to the field, with really nice, clear-cut conclusions,” says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution